Clay Thorp - Jun 20, 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 04:15 PM
Previous filing
Sep 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +45K $0.00 45K Jun 20, 2024 Common Stock 45K $1.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2025, subject to the Reporting Person's continuous service as of such vesting date.